Dyspnea in a Young Patient Undergoing in Vitro Fertilization Treatment

Clinical Image

Volume 4, Issue 10 (October Issue)

Dyspnea in a Young Patient Undergoing In vitro Fertilization Treatment

Miriam Manzanares Garcia-Faria^1*, Iñaki Marina Clopes² and Magdalena Muelas Fernandez²

¹Family physician, Costa Ponent Teaching Unit, Metropolitan South, Institut Català de la Salut, Viladecans (Barcelona), Spain

²Internal Medicine Department, Hospital of Viladecans, Institut Català de la Salut, Viladecans (Barcelona), Spain

^*Corresponding author: Miriam Manzanares Garcia-Faria, Family physician, Costa Ponent Teaching Unit, Metropolitan South, Institut Català de la Salut, Viladecans (Barcelona), Spain. E-mail: miriamgf82@gmail.com

Received: September 12, 2022; Accepted: September 19, 2022; Published: October 04, 2022

Citation: Manzanares - Garcia-Faria M, Marina - Clopes I, Muelas - Fernandez M. Dyspnea in a Young Patient Undergoing In vitro Fertilization Treatment. Clin Image Case Rep J. 2022; 4(10): 266.

Download PDF

Abstract

A 32-year-old woman was admitted to our internal medicine ward for dyspnea and pain in right hemithorax. Patient was on folic acid 5 mg/day and progesterone 600 mg/day due to invitro-fertilization treatment. Physical examination revealed heart rate was 110 bpm, Oxygen saturation was 93% and right basal hypophonesis on her chest was noted. The dyspnea-onset started 5 days before eventually progressing at rest. Laboratory findings indicated increased hematocrit and leukocytosis with evidence of hypersegmented neutrophils (Hematocrit 48%, WBC 19.5 x 109/L-Neutrophils 84.5%). X-rays revealed moderate pleural effusion in right hemithorax and CT-scan showed no signs of pulmonary embolism but confirmed bilateral pleural effusion with a right predominance and free peri-splenic fluid. In addition, a transvaginal-US was performed (Figure 1).

Keywords: Ovarian hyperstimulation syndrome; Assisted reproductive technology